167824-49-9 Usage
Uses
Used in Pharmaceutical Applications:
(4R,5S,6S,7R)-1,4,7-tribenzyl-5,6-dihydroxy-3-(5-hydroxypentyl)-1,3-diazepan-2-one is used as a potential pharmaceutical agent due to its unique structure and functional groups. The presence of multiple hydroxyl groups and a diazepan ring suggests that (4R,5S,6S,7R)-1,4,7-tribenzyl-5,6-dihydroxy-3-(5-hydroxypentyl)-1,3-diazepan-2-one may have biological activity, making it a candidate for further study and development in the pharmaceutical industry.
Used in Chemical Research:
In the field of chemical research, (4R,5S,6S,7R)-1,4,7-tribenzyl-5,6-dihydroxy-3-(5-hydroxypentyl)-1,3-diazepan-2-one is used as a subject of study for its unique stereochemistry and the potential interactions between its various functional groups. Understanding the compound's properties and reactivity can contribute to the advancement of organic chemistry and the development of new synthetic methods or applications.
Used in Drug Delivery Systems:
(4R,5S,6S,7R)-1,4,7-tribenzyl-5,6-dihydroxy-3-(5-hydroxypentyl)-1,3-diazepan-2-one may be utilized in the development of drug delivery systems, taking advantage of its multiple functional groups and unique structure to improve the delivery, bioavailability, and therapeutic outcomes of various pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 167824-49-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,8,2 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 167824-49:
(8*1)+(7*6)+(6*7)+(5*8)+(4*2)+(3*4)+(2*4)+(1*9)=169
169 % 10 = 9
So 167824-49-9 is a valid CAS Registry Number.
167824-49-9Relevant academic research and scientific papers
Functionalized aliphatic P2/P2' analogs of HIV-1 protease inhibitor DMP323
Smallheer, Joanne M.,McHugh, Robert J.,Chang, Chong-Hwan,Kaltenbach III, Robert F.,Worley, Tabitha V.,Klabe, Ronald M.,Bacheler, Lee T.,Rayner, Marlene M.,Erickson-Viitanen, Susan,Seitz, Steven P.
, p. 1365 - 1370 (2007/10/03)
A series of analogs of HIV protease inhibitor DMP323 containing functionalized aliphatic P2/P2' groups was prepared and evaluated for HIV protease inhibition and antiviral activity in a cell-based assay. Asymmetric compounds with a 5-hydroxypentyl substituent at P2 and a benzylic substituent at P2' showed increased potency over the corresponding symmetrically substituted analogs.
